Sadri, Amir Reza
Azarianpour, Sepideh
Chirra, Prathyush
Singh, Sneha
DeSilvio, Thomas
Madabhushi, Anant
Viswanath, Satish E.
Article History
Received: 4 February 2025
Accepted: 17 December 2025
First Online: 28 January 2026
Competing interests
: A.M. has had technology licensed to and is an equity holder in Picture Health, Elucid Bioimaging, and Inspirata Inc. Currently he serves on the advisory board of Picture Health and SimBioSys. He currently consults for Takeda Inc. He also has sponsored research agreements with AstraZeneca and Bristol Myers-Squibb. He is also a member of the Frederick National Laboratory Advisory Committee. The other authors declare no competing interests.